treatment-resistant depression

colorful brain art model
Biotech

Beckley Psytech psychedelic reduces depression symptoms in ph. 2

Beckley Psytech’s psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study.
James Waldron Jul 1, 2025 8:30am
compass map direction find trail north

Compass' psychedelic therapy wins ph. 3, investors unimpressed

Jun 23, 2025 8:05am
forest woods paths paths diverge

Supernus depression drug candidate fails midstage trial

Feb 19, 2025 6:40am
compass map direction find trail north

Compass delays phase 3 psychedelic data, lays off 30% of staff

Oct 31, 2024 9:00am
brain amyloid alzheimers strings detailed web complicated thought

Abbott begins neuromodulation trial in drug-resistant depression

Sep 4, 2024 11:02am
Motif Neurotech DOT

Motif Neuro raises $19M for brain pacemaker depression treatment

Jan 24, 2024 10:17am